MAPT and Alzheimer disease: GSK3β (or GSK3β-S9A [77]) overexpression in cortical and hippocampal neurons results in AD-like neurodegeneration as indicated by increased phosphorylation and somatodendritic localization of tau proteins in hippocampal neurons [78].